Objective: To report the rational, design, recruitment, baseline characteristics and preliminary overview of volunteers in the ZENITH study. Design: A multicentre prospective intervention study employing a randomised double-blind design. Setting: Clermont-Ferrand, Theix (France), Coleraine (Northern Ireland), Grenoble (France), Rome (Italy). Participants: Healthy men and women middle-aged (55-70 y) and older volunteers (70-87 y). Interventions: At baseline (prior to zinc (Zn) supplementation), all volunteers underwent a full clinical examination, anthropometric measurements, health and lifestyle questionnaire, Mini Mental State Examination, Geriatric Depression Scale, and biochemistry profile. Results: In total, 842 volunteers (378 men and 464 women) were invited to take part in the study. A total of 49% of these volunteers were excluded on the basis of inclusion/exclusion criteria. In total, 433 participants were admitted to the Zn supplementation for 6 months. During this period, about 10% of volunteers dropped out from the study. Conclusions: A total of 387 subjects (197 male and 190 female subjects) successfully completed the supplementation phase of the ZENITH study.
Introduction
ZENITH is a multicentre study involving healthy middleaged and older participants. The acronym of the project 'ZENITH' is derived from the words: Zinc Effects on Nutrient/ nutrient Interactions and Trends in Health and ageing. The overall aim of the study was to investigate the effects of zinc, given as a nutritional supplement to late middle-aged and older population groups, on psychological and behavioural factors and on surrogate markers (particularly antioxidants/ oxidative stress balance, immunity and thyroid functions, bone metabolism and protein synthesis) that are indicative of trends towards better health in these vulnerable population groups. The project will provide a scientific basis for formulation of public health recommendations on dietary zinc intake in aged Europeans. In order to achieve the overall objective of the project, two levels of zinc supplementation (15/30 mg/day) were given for 6 months using a placebocontrolled, double-blinded design. The health measures and physiological processes of the study are shown in Figure 1 . The present paper outlines the recruitment and screening procedures used in the ZENITH study.
Recruitment, screening and enrolment procedures
The multicentred Zn intervention study was conducted in three European countries (France, Northern Ireland and Italy), involving four different research centres (INRAClermont-Ferrand, UJF-Grenoble, UU-Coleraine, INRANRome). Participants were apparently healthy men and women volunteers between 55 and 70 y of age (late middleaged population) and between 70 and 87 y of age (older population). The middle-aged subjects were recruited in France (Clermont-Ferrand, Theix) and Northern Ireland (Coleraine), while older subjects were recruited in France (Grenoble) and Italy (Rome). The volunteers were contacted in each centre using various methods (letter; local media such as television and radio; posters; leaflets in supermarkets, clubs and organizations that free-living elderly subjects frequent; contact with Health Centres and family doctors; phone; personal contact). Volunteers were screened and enrolled in the study according to inclusion/exclusion criteria as outlined in Table 1 . Each volunteer was contacted by telephone to arrange an appointment for clinical examination, anthropometric measurements, interview for the assessment of dietary habits, smoking and alcohol consumption, cognitive impairment and depression.
Clinical examination
Information on personal medical and surgical history, the concomitant use of medication or nutritional supplements influencing Zn absorption or status and dietary regimes were collected by a general interview. A complete clinical checkup was also performed and participants with pathological diseases, which can present a risk for the volunteers or likely to modify the influence on the outcome were excluded. Blood pressure was measured in a quiet room after the participants were rested (WHO, 1996) .
Anthropometry
Body weight and height were measured according to the standard procedure (Lohman et al, 1988 
Smoking and alcohol consumption
Information on smoking and alcohol consumption were determined by a Health and Lifestyle questionnaire. According to WHO guidelines (WHO, 1998), both men and women who regularly smoked more than 10 g of tobacco/day were excluded. Male subjects consuming more than 30 g of alcohol/day and female subjects consuming more than 20 g of alcohol/day were also excluded (James, 2001) .
Cognitive impairment and depression
Cognitive impairment and depression were evaluated by the Mini Mental State Examination (MMSE) (Folstein et al, 1975) and Geriatric Depression Scale (GDS) (Yesavage et al, 1983) , respectively. MMSE is a 30-item cognitive scale that investigates orientation, immediate and short-term recall, language and the ability to follow simple verbal and written instructions. The total score decreases as cognitive impairment increases and a score of 23 or less indicates a need for further assessment even if people whose low scores may be due to limited education (Folstein et al, 1975) : participants with scores below 23 were excluded. A 15-item version of GDS was used to screen depressive symptoms and their severity in the elderly (Yesavage et al, 1983) . Scores of 0-5 indicates no depression, 6-10 indicates mild depression and 11-15 indicates severe depression. Participants with a score more than 5 were excluded. If the above criteria were met, a biochemistry profile, which included a full blood profile, liver and kidney function, was performed.
Biochemistry profiles
Overnight fasting peripheral venous blood samples were obtained using vacutainers with either EDTA or heparin by a qualified nurse or phlebotomist. An aliquot of blood and/or plasma were used for the following determinations: full blood profile (white blood cells, red blood cells, haemoglobin, hematocrit, globular volume, platelets, neutrophils, eosinophils, basophils, lymphocytes, monocytes), hepatic function tests (alanine aminotransferase, aspartate aminotransferase, g-glutamyltranspeptidase, bilirubin), renal function tests (serum creatinine), inflammation indicators (C-reactive protein), HIV and hepatitis C virus serology tests.
All procedures were standardised for all four research centres and a manual of standard operating procedures 'Practical guidelines for recruitment of volunteers, samples and data collection' was produced for use in all centres. Furthermore, before the recruitment process was initiated, researches from all four centres underwent a collective training workshop in France (Clermont-Ferrand) and England (Cambridge). This workshop also helped in finalisation of various questionnaires, which were translated from English into Italian and French. Data for each volunteer were collected in a standardised report form, 'The Case Report Document' by trained personnel in each centre.
Ethical considerations
Ethical approval for the study was provided by the French Ethic Committee in France, University of Ulster Ethical Committee in Northern Ireland and the Ethical Committee of the Italian National Research Centres on Aging (I.N.R.C.A.) in Italy. A complete description of the study was given to the volunteers and the written informed consent was obtained for each of the participants.
Study population
All centres initiated volunteer enrolment between November and December 2002 and following screening, the selected patients started their Zn supplementation between January and December 2003. The centres involved in the recruitment of the older population group (Italy and France-Grenoble) enrolled their volunteers at two different time periods because of the difficulties in recruiting older people who met the strict inclusion criteria, and so as to allow for the replacement of participants who withdrew from the study. The distribution of participants by centre and sex is displayed in Figure 2 . In total, 842 volunteers (45% men and 55% women) were invited to take part in the study and were screened. A total of 49% of these volunteers were not selected for inclusion in the intervention phase of the study on the basis of inclusion/exclusion criteria. Pathological conditions or use of medication and drugs represented the main reasons why subjects were excluded, especially in the older population group (as outlined in Table 2 ). A total of 433 participants were admitted to the supplementation phase of the study (for more details, see Figure 2 ). In each centre, participants were divided into three groups for each level of Zn supplementation (placebo, 15 mg Zn/day, 30 mg Zn/day) as Zn gluconate. The distribution of the volunteers into the three groups was made randomly, by using function ALEA under Excel. The randomisation process was standardised for the four centres. During the supplementation phase of the study, 43 participants dropped out from the study: 13 participants aged 55-70 y (one participant in France and 12 volunteers in Northern Ireland) and 30 participants aged 70-85 y (nine in France and 21 participants in Italy). In addition, three volunteers in the Italian centre were excluded because their compliance was less than 80%. At the end of the intervention phase, a total of 387 participants (196 male and 191 female subjects) have successfully completed the Zinc supplementation trial. The physical characteristics of these subjects (the ZENITH sample) at baseline are reported in Table 3 . Mean BMI indicates a moderate overweight in all participating centres.
Discussion
The ZENITH project is an intervention study that uses a global nutritional and psychological approach to test the effect of zinc as nutritional supplement. The project called for several efforts to select eligible volunteers in all centres especially to comply with selection criteria. One of the major problems in these criteria was that there is a high number of aged people with different pathologies (mainly diabetes), a large percentage of obesity and, in the average, the number of used drugs is high. Moreover, several volunteers refused to participate in the study and about 11% dropped out from the study during the supplementation phase of the study. These difficulties suggest that it is essential for the achievement of the expected results to pay attention to the recruitment phase by selecting a larger sample of volunteers compared to the size requested. The use of local media in all their forms (television radio and press, etc.) in order to explain the aim of the study can contribute to the success of the volunteers' participation. A preliminary overview of comparative results at baseline on the ZENITH sample that have successfully completed the Zinc supplementation trial is presented in separated papers in the edition of this supplement.
